As shown in Figure 1, the subset of centenarian offspring who are resistant to AD pathology would be those who maintain low levels of beta-amyloid and tau burden in spite of increasing age or in comparison to age-matched referents as ascertained during assessments from midlife through late adulthood. The gene discussed is MAPT; the disease is Alzheimer disease.